Yüklüyor......
Biologics
Currently, ~28–30 mAbs are approved or under consideration for approval as specific therapies in the USA or European Union, although about 350 new mAbs for therapeutic application in humans are in the commercial pipeline. So far, the number of target antigens for the mAbs is surprisingly small with...
Kaydedildi:
| Yayımlandı: | Drug Allergy |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7121109/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-1-4614-7261-2_11 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|